Related Experiment Video
Updated: Aug 16, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease
Julie Fotheringham1, Steven Jacobson
1Viral Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Multiple sclerosis (MS) is a debilitating neurological disease of unknown cause that affects people between 20 and 40 years of age. While several viruses have been associated with MS, none has proven causative. Human herpesvirus 6 (HHV-6) is one agent that may play a role in MS. Some studies have demonstrated an association between HHV-6 and MS based on immunological and molecular data, suggesting that a subset of MS patients may have reactivation of this widespread herpesvirus. New studies investigating the biology of HHV-6 have given insights towards understanding how HHV-6 may play a role in MS pathology. By inducing molecular mimicry or excessive complement activation, HHV-6 reactivation may have the potential to trigger autoimmunity and tissue damage associated with MS lesion development.
Insights
Human herpesvirus 6 (HHV-6) reactivation may trigger multiple sclerosis (MS) by inducing molecular mimicry or complement activation. This widespread virus could play a role in MS pathology and autoimmune responses.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Multiple sclerosis (MS) is a disabling neurological disease with unknown causes, typically affecting young adults.
- Several viruses are suspected to be linked to MS, but none have been definitively identified as causative agents.
- Human herpesvirus 6 (HHV-6) is a common virus that has been investigated for its potential role in MS pathogenesis.
Purpose of the Study:
- To explore the potential role of Human herpesvirus 6 (HHV-6) in the development of multiple sclerosis (MS).
- To understand the biological mechanisms by which HHV-6 reactivation might contribute to MS pathology.
Main Methods:
- Review of existing immunological and molecular data.
- Investigation into the biological mechanisms of HHV-6.
- Analysis of potential triggers for autoimmunity and tissue damage in MS.
Main Results:
- Some studies show an association between HHV-6 and MS.
- Evidence suggests a subset of MS patients may experience HHV-6 reactivation.
- HHV-6 reactivation may induce molecular mimicry or excessive complement activation.
Conclusions:
- HHV-6 reactivation is a potential factor in MS pathology.
- Mechanisms like molecular mimicry and complement activation by HHV-6 could trigger autoimmunity in MS.
- Further research is needed to confirm HHV-6's causative role in MS lesion development.
Related Concept Videos
Herpes
Multiple Sclerosis l: Introduction
Genital Herpes
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Chickenpox

